The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-chloro-N4-(2-isopropylsulfonylphenyl)-N2-[5-methyl-4-(4-piperidyl)-2-(trideuteriomethoxy)phenyl]pyrimidine-2,4-diamine ID: ALA4464582
PubChem CID: 138454797
Max Phase: Preclinical
Molecular Formula: C26H32ClN5O3S
Molecular Weight: 530.09
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: [2H]C([2H])([2H])Oc1cc(C2CCNCC2)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1
Standard InChI: InChI=1S/C26H32ClN5O3S/c1-16(2)36(33,34)24-8-6-5-7-21(24)30-25-20(27)15-29-26(32-25)31-22-13-17(3)19(14-23(22)35-4)18-9-11-28-12-10-18/h5-8,13-16,18,28H,9-12H2,1-4H3,(H2,29,30,31,32)/i4D3
Standard InChI Key: BXJYIWUWXJWABE-GKOSEXJESA-N
Molfile:
RDKit 2D
39 42 0 0 0 0 0 0 0 0999 V2000
8.2462 -3.2605 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.6589 -3.9704 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
9.0673 -3.2580 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.7172 -4.3996 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7161 -5.2191 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4241 -5.6281 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1338 -5.2187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1309 -4.3960 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4223 -3.9907 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4239 -6.4453 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7149 -6.8475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7127 -7.6612 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4185 -8.0738 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.1281 -7.6666 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1319 -6.8468 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8421 -5.6261 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4199 -3.1735 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.1264 -2.7628 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8332 -3.1717 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.5392 -2.7617 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5372 -1.9436 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8233 -1.5373 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1202 -1.9497 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.2479 -3.1685 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.2431 -1.5320 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
7.2500 -3.9857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5422 -4.3905 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5439 -5.2070 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2532 -5.6146 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9622 -5.1998 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9570 -4.3848 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3724 -4.3734 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0762 -3.9582 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3801 -5.1906 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0094 -3.9912 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.3018 -4.3999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5940 -3.9915 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
2.3020 -5.2171 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
1.5890 -4.8041 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
6 10 1 0
10 11 1 0
10 15 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
7 16 1 0
9 17 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
20 24 1 0
21 25 1 0
24 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 30 1 0
30 31 2 0
31 26 1 0
31 2 1 0
2 32 1 0
32 33 1 0
32 34 1 0
4 35 1 0
35 36 1 0
36 37 1 0
36 38 1 0
36 39 1 0
M ISO 3 37 2 38 2 39 2
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 530.09Molecular Weight (Monoisotopic): 529.1914AlogP: 5.58#Rotatable Bonds: 8Polar Surface Area: 105.24Molecular Species: BASEHBA: 8HBD: 3#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): 2CX Acidic pKa: 11.58CX Basic pKa: 10.07CX LogP: 5.03CX LogD: 2.60Aromatic Rings: 3Heavy Atoms: 36QED Weighted: 0.35Np Likeness Score: -1.14
References 1. Das D, Wang J, Li Y, Shi J, Hong J.. (2019) Design, synthesis of orally bioavailable novel anaplastic lymphoma kinase (ALK) inhibitor diphenylaminopyrimidine analogs and efficacy study on NCI-H2228 xenografts mice model., 29 (12): [PMID:31005443 ] [10.1016/j.bmcl.2019.04.012 ]